Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Capricor Therapeutics Inc (CAPR)

Pharmaceutical Preparations

https://www.capricor.com

Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.

8840 WILSHIRE BLVD, 2ND FLOOR
BEVERLY HILLS, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/13/2007

Market Cap

126,576,321

Shares Outstanding

30,790,000

Weighted SO

30,792,869

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

BPTH --.--%

CBIO --.--%

DFFN --.--%

NXTC --.--%

PULM --.--%

AKTX --.--%

SLNO --.--%

UNCY --.--%

CDTX --.--%

Beta

4.0150

Last Div

0.0000

Range

2.68-8.22

Chg

-0.0100

Avg Vol

438533

Mkt Cap

126576321

Exch

NASDAQ

Country

US

Phone

310 358 3200

DCF Diff

5.2117

DCF

-0.1717

Div Yield

0.0000

P/S

4.6617

EV Multiple

-4.2065

P/FV

10.7687

Div Yield %

0.0000

P/E

-4.4322

PEG

-0.1615

Payout

0.0000

Current Ratio

1.3719

Quick Ratio

1.3719

Cash Ratio

0.4781

DSO

4.9735

DIO

0.0000

Op Cycle

4.9735

DPO

1769.8762

CCC

-1764.9028

Gross Margin

0.9531

Op Margin

-1.0970

Pretax Margin

-1.0293

Net Margin

-1.0293

Eff Tax Rate

0.0099

ROA

-0.7301

ROE

-2.2026

ROCE

-1.8706

NI/EBT

1.0000

EBT/EBIT

0.9383

EBIT/Rev

-1.0970

Debt Ratio

0.1089

D/E

0.3624

LT Debt/Cap

0.2269

Total Debt/Cap

0.2660

Int Coverage

0.0717

CF/Debt

-8.1425

Equity Multi

3.3278

Rec Turnover

73.3893

Pay Turnover

0.2062

Inv Turnover

0.0000

FA Turnover

3.7253

Asset Turnover

0.7094

OCF/Share

-1.0661

FCF/Share

-1.1322

Cash/Share

0.9253

OCF/Sales

-1.2502

FCF/OCF

1.0620

CF Coverage

-8.1425

ST Coverage

-42.8234

CapEx Coverage

-16.1171

Div&CapEx Cov

-16.1171

P/BV

10.7687

P/B

10.7687

P/S

4.6617

P/E

-4.4322

P/FCF

-3.5109

P/OCF

-3.6489

P/CF

-3.6489

PEG

-0.1615

P/S

4.6617

EV Multiple

-4.2065

P/FV

10.7687

DPS

0.0000

Latest Headlines (EST)

Benzinga May 16, 22:36 CAPR Investors Have Opportunity to Join Capricor Therapeutics, Inc. Fraud Investigation with the Schall Law Firm GlobeNewswire Inc. Nov 07, 09:15 Capricor Therapeutics to Present Third Quarter 2023 Financial Results and Recent Corporate Update on November 14

Revenue Product Segmentation